• Biocartis announces new collaboration with AstraZeneca to expand availability of Idylla™ EGFR biomarker testing among patients with lung cancer

    Wednesday May 5th 2021

  • miDiagnostics accelerates with launch of rapid COVID-19 PCR test product

    Monday May 3rd 2021

  • New cancer immunotherapy treatment enters clinical phase

    Thursday April 29th 2021

  • Precirix partners with Evergreen to expand North American clinical trial supply

    Wednesday April 28th 2021

  • Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies

    Friday April 23rd 2021

  • Biocartis and SkylineDx sign collaboration to develop the Merlin Assay

    Thursday April 22nd 2021

  • Biotalys appoints Simon Moroney as Chairman of the Board

    Wednesday April 21st 2021

  • Celyad Oncology appoints Dr. Charles Morris as Chief Medical Officer

    Tuesday April 20th 2021

  • Your news here?

  • Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test

    Tuesday April 20th 2021

  • PCR speekseltesten op de werkvloer identificeren besmette laag-risico contacten zonder symptomen en helpen de verdere verspreiding tegengaan

    Monday April 19th 2021

  • Latest Neuropixels probes can track neurons over weeks

    Friday April 16th 2021


Strategic Partners